Search PubMed⌕ Search

Biomedical subjects

F A Davis

Publications and source records attributed to F A Davis.

At least 73 records · Page 4Linked to original sources
PubMed1976

Movement phosphenes in optic neuritis: a new clinical sign.

Positive visual phenomena (phosphenes) elicited by eye movements have been described in normal individuals and in myopes with vitreous opacities. In the present paper we describe eye movement-induced phosphenes that appear to be related to optic nerve involvement in patients with optic neuritis and multiple sclerosis. This phenomenon is not associated with vitreous or retinal defects, nor is it similar to phosphenes observed in normal individuals. Instead, it shares many characteristics with the well-known Lhermitte sign and is believed to represent a similar phenomenon.

Adult↗
PubMed1976

Aminopyridines and sparteine as inhibitors of membrane potassium conductance: effects on Myxicola giant axons and the lobster neuromuscular junction.

The effects of the compounds 2-, 3- and 4-aminopyridine and sparteine on membrane conductance changes were examined using both voltage-clamped Myxicola axons and the lobster neuromuscular junction. In Myxicola axons, the aminopyridines very specifically inhibited the potassium conductance when applied at concentrations of 0.1 mM to 5 mM without any apparent effect of resting membrane potential. Concentrations in excess of 5 mM were needed to inhibit noticeably the sodium conductance. Potassium conductance-voltage curves were shifted in the depolarized direction along the voltage axis with no significant change in shape. There were only minor changes in the kinetics of potassium activation. In high potassium solutions, both inward and outward potassium currents were equally sensitive to the aminopyridines. Sparteine was, in general, found to be a more potent, but somewhat less specific, inhibitor of the potassium conductance. In contrast to the aminopyridines, sparteine was more effective when applied at basic pH and in addition tended to produce a noticeable degree of potassium inactivation. When applied to the lobster neuromuscular junction, 2-aminopyridine and sparteine dramatically increased the amplitude of both excitatory and inhibitory postjunctional potentials, with little or no change in resting potential, resting input conductance, reversal potential, or miniature end plate potential amplitude or frequency. Quantal content per fiber was increased by approximately a factor of 3 for the excitatory responses.

Animals↗
PubMed1975

Further studies of activation-inactivation coupling in Myxicola axons. Insensitivity to changes in calcium concentration.

In Myxicola axons subjected to moderate depolarizations the sodium inactivation time constants obtained from the decay of sodium current during a maintained depolarizatin (TSh) are substantially smaller than inactivation time constants determined at the same potential from the effect of changes in the duration of conditioning prepulses (Tph). This report extends these observations to positive membrane potentials and demonstrates that for sufficiently large depolarizations TSh and Tph become comparable. The ratio of inactivation time constants, Tph/TSh, is unaffected by changes in [Ca++] provided total divalent cation concentration is maintained constant, while changes in total divalent ion concentrations produce simple voltage shifts comparable to those obtained from measurement of membrane sodium or potassium conductances. Sodium inactivation delay was quantitatively determined as a function of membrane potential, and found to be similarly unaffected by changes in [Ca++] at constant total divalent ion concentration. Inactivation delay is, however, directly proportional to the activation rate constant over a wide range of potentials.

Animals↗
PubMed1975

Actions of the antidepressant drug imipramine on the voltage-clamped Myxicola giant axon.

The effects of the antidepressant drug imipramine were studied on the voltage-clamped Myxicola giant axon at concentrations from 10- minus 6 to 5 X 10- minus 5 M. Over this range, imipramine reversibly reduced both the sodium and potassium conductances without having any substantial effect on either the resting membrane potential or the leakage conductance. The observed dose-response relation is described by a Langmuir adsorption isotherm with an apparent dissociation constant of 9 X 10-minus 6 M. The sodium and potassium conductance-voltage curves are shifted in the hyperpolarizing direction along the voltage axis, the magnitude of the displacement increasing with increasing concentrations of imipramine. There was no significant effect of imipramine on either time to peak sodium current or time to half-maximum steady-state current.

Animals↗
PubMed1974

Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents.

The simplest model for explaining conduction defects in multiple sclerosis (MS) and other demyelinating diseases assumes that the only abnormality present is loss of myelin. The consequences of such an assumption have been investigated by numerical solution of a well-known set of differential equations describing conduction in a model demyelinated axon. In agreement with clinical findings, we show that this model predicts that the temperature at which conduction block occurs is a steep function of the extent of demyelination, so that small temperature increases may block large numbers of conducting fibres. Decreasing calcium concentration (or increasing pH) is calculated markedly to improve the conduction velocity of conducting demyelinated fibres and will, in addition, restore conduction in blocked fibres. The effects of other pharmacological agents have also been computed. The presence of a demyelinating lesion in a nerve fibre is shown greatly to impair the ability of the fibre to conduct repetitive impulses, conduction failing at much lower frequencies than in normal fibres. These calculations provide some insight into the nature of conduction defects in demyelinated nerve, demonstrate that many clinical features of MS are the expected consequence of loss of myelin and do not require the presence of other defects for their explanation, and provide a useful approach to the search for a symptomatic therapy.

Axons↗